CDKN2A and melanoma: Our study was limited to the PTEN loss-mediated bypass of OIS on the NRASQ61K background, but the PTEN/CAV1/β-catenin/p16INK4A pathway may hold true in BRAFV600E melanomas as well (Supplementary Fig. 4a–c).